glp-1 do you need prescription How to Get a From Coryell Health GLP-1s & ADHD Meds: Safety,

Dual medication offerings The availability of both compounded tirzepatide and compounded semaglutide under one roof is genuinely useful

However, safety continues to be a concern as there have been reports of adverse reactions, which range from mild, transient headaches and skin eruptions to severe drug reactions requiring hospitalization

Then in April 2025, Pfizer announced the discontinuation of danuglipron itself after a case of potential drug-induced liver injury was identified in one participant during a dose-optimization study

Japan: Demand for GLP-1 receptor agonists in Japan is projected to rise at 6.4% CAGR through 2036

Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W et al

Clinical trials extending 68 weeks show acceptable safety profiles with no unexpected serious adverse events